XML 64 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Tables)
12 Months Ended
Dec. 31, 2022
Schedule of Investments at Amortized Cost and Fair Value
Short-term investments classification as of December 31, 2021 and 2022 were shown as below:
 
    
As of December 31, 2021
 
    
Cost or
Amortized
cost less
allowance
for credit
losses
    
Gross
unrecognized
holding gains
    
Gross
unrecognized
holding
losses
    
Gross
unrealized
gains
    
Gross
unrealized
losses
    
Fair

value
 
  
RMB
    
RMB
    
RMB
    
RMB
    
RMB
    
RMB
 
    
(In millions)
 
Held-to-maturity
debt investments
     140,686        898        —          —          —          141,584  
Available-for-sale
debt investments
     2,547        —          —          10        —          2,557  
 
   
As of December 31, 2022
 
   
Cost or
Amortized
cost less
allowance
for credit
losses
   
Gross
unrecognized
holding gains
   
Gross
unrecognized
holding
losses
   
Gross
unrealized
gains
   
Gross
unrealized
losses
   
Fair value
 
 
RMB
   
RMB
   
RMB
   
RMB
   
RMB
   
RMB
   
US$
 
   
(In millions)
 
Held-to-maturity
debt investments
    119,984       631       (151     —         —         120,464       17,466  
Available-for-sale
debt investments
    847       —         —         8       —         855       124  
Schedule of Unrealized and Realized Gains and Losses of Equity Securities Without Readily Determinable Fair Values
Total unrealized and realized gains and losses of equity securities without readily determinable fair values that do not qualify for
the
NAV practical expedient for the years ended December 31, 2020, 2021 and 2022 were as follows:
 
    
For the years ended

December 31,
 
    
2020
   
2021
   
2022
   
2022
 
    
RMB
   
RMB
   
RMB
   
US$
 
    
(In millions)
 
Gross unrealized gains
     4,396       1,062       218       32  
Gross unrealized losses (including impairment)
(i)
     (2,679     (4,424     (2,418     (351
    
 
 
   
 
 
   
 
 
   
 
 
 
Net unrealized gains (losses) on equity securities held
     1,717       (3,362     (2,200     (319
Net realized gains on equity securities sold
     266       —         90       13  
    
 
 
   
 
 
   
 
 
   
 
 
 
Total net gains (losses) recognized
     1,983       (3,362     (2,110     (306
    
 
 
   
 
 
   
 
 
   
 
 
 
 
(i)
Gross unrealized losses (downward adjustments excluding impairment) were RMB378 million, RMB165 million and nil for the years ended December 31, 2020, 2021 and 2022, respectively.
Equity Method Investments
The following tables set forth the summarized financial information of Trip:
 
    
As of September 30,
(i)
 
    
2021
    
2022
    
2022
 
    
RMB
    
RMB
    
US$
 
    
(In millions)
 
Current assets
     76,596        67,045        9,422  
Non-current
assets
     124,268        127,253        17,883  
Current liabilities
     73,517        61,708        8,672  
Non-current
liabilities
     16,418        21,647        3,042  
Noncontrolling interests
     924        713        100  
 
    
For the twelve months ended

September 30,
(i)
 
    
2020
   
2021
   
2022
   
2022
 
    
RMB
   
RMB
   
RMB
   
US$
 
    
(In millions)
 
Total revenues
     21,704       20,313       19,706       2,769  
Gross profit
     16,838       15,916       15,261       2,145  
Loss
 
from operations
     (827     (723     (376     (53
Net (loss) income
     (2,236     1,198       (1,596     (224
Net (loss) income attributable to
Trip
     (2,243     1,288       (1,488     (209
 
(i)
The Group adopted a
one-quarter
lag in reporting its share of equity income (loss) in Trip.
Summary Of Estimated Fair Value Of Available-For-Sale Debt Investments
The following table summarizes the estimated fair value of
available-for-sale
debt investments with stated contractual dates, classified by the contractual maturity date of the investments:
 
    
As of December 31,
 
    
2021
    
2022
    
2022
 
    
RMB
    
RMB
    
US$
 
    
(In millions)
 
Due in 1 year
     —          —          —    
Due in 1 year through 5 years
     1,685        1,581        229  
Not due at a single maturity date
     577        866        126  
    
 
 
    
 
 
    
 
 
 
Total
     2,262        2,447        355  
    
 
 
    
 
 
    
 
 
 
Long Term Investments  
Schedule of Investments at Amortized Cost and Fair Value
Long-term investments classification, excluding equity method investments and equity investments without readily determinable fair value, as of December 31, 2021 and 2022 are shown as below:
 
    
As of December 31, 2021
 
    
Cost or
Amortized cost
    
Gross
unrealized
gains
    
Gross
unrealized
losses
   
Fair
value
 
    
RMB
    
RMB
    
RMB
   
RMB
 
    
(In millions)
 
Equity investments at fair value with readily determinable fair value
     15,046        6,046        (4,717     16,375  
Available-for-sale
debt investments
     2,820        216        (774     2,262  
Investments accounted for at fair value
     1,974        2,653        (399     4,228  
 
    
As of December 31, 2022
 
    
Cost or
Amortized cost
    
Gross
unrealized
gains
    
Gross
unrealized
losses
   
Fair value
 
    
RMB
    
RMB
    
RMB
   
RMB
    
US$
 
    
(In millions)
 
Equity investments at fair value with readily
determinable fair value
     15,835        2,731        (6,466     12,100        1,754  
Available-for-sale
debt investments
     3,735        283        (1,571     2,447        355  
Investments accounted for at fair value
     2,331        2,855        (570     4,616        669  
Summary of Break Down of Long Term Investments
The following table sets forth a breakdown of the categories of long-term investments held by the Group as of the dates indicated:
 
    
As of December 31,
 
    
2021
    
2022
    
2022
 
    
RMB
    
RMB
    
US$
 
    
(In millions)
 
Equity investments at fair value with readily determinable fair value
     16,375        12,100        1,754  
Equity investments without readily determinable fair value using
the
NAV practical expedient
     957        945        137  
Equity investments without readily determinable fair value using
the
measurement alternative
     10,788        9,249        1,341  
Available-for-sale
debt investments
     2,262        2,447        355  
Equity method investments
     24,808        25,940        3,761  
Investments accounted for at fair value
     4,228        4,616        669  
    
 
 
    
 
 
    
 
 
 
Total long-term investments
     59,418        55,297        8,017  
    
 
 
    
 
 
    
 
 
 
Other Equity Method Investees Excluding Ctrip Com Member [Member]  
Equity Method Investments Financial information for the Group’s equity method investments other than Trip are summarized as a group as follow:
 
    
As of September 30,
(i)
 
    
2021
    
2022
    
2022
 
    
RMB
    
RMB
    
US$
 
    
(In millions)
 
Current assets
     125,266        163,889        23,031  
Non-current
assets
     18,512        19,781        2,780  
Current liabilities
     90,744        117,811        16,556  
Non-current
liabilities
     9,218        15,750        2,213  
Noncontrolling interests
     1,662        1,721        242  
 
    
For the twelve months ended
September 30,
(i)
 
    
2020
   
2021
    
2022
    
2022
 
    
RMB
   
RMB
    
RMB
    
US$
 
    
(In millions)
 
Total revenues
     13,981       21,380        22,417        3,150  
Gross profit
     5,083       7,624        8,664        1,218  
(Loss) income from operations
     (1,282     1,238        993        140  
Net (loss) income
     (832     2,065        304        43  
Net (loss) income attributable to the investees
     (891     2,040        249        35  
 
(i)
The Group adopted a
one-quarter
lag in reporting its share of (loss) income in majority of its equity investees.
Equity Method Investments  
Schedule of Unrealized and Realized Gains and Losses of Equity Securities Without Readily Determinable Fair Values
The total carrying value of equity investments without readily determinable fair value that do not qualify for the NAV practical expedient held as of December 31, 2021 and 2022 were as follows:
 
    
As of

December 31,
2021
   
As of

December 31,
2022
   
As of

December 31,
2022
 
    
RMB
   
RMB
   
US$
 
    
(In millions)
 
Initial cost basis
     13,016       13,741       1,992  
Cumulative unrealized gains
     3,910       4,026       584  
Cumulative unrealized losses (including impairment)
     (6,138     (8,518     (1,235
    
 
 
   
 
 
   
 
 
 
Total carrying value
     10,788       9,249       1,341